Company Search:
Advanced Search
Sponsored Links
Immutep Ltd - ADR Company Snapshot
Immutep Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Immutep Ltd with three other companies in this sector in UNITED STATES : Starpharma Holdings Limited (2020 sales of $4.77 million of which 100% was endrimers for pharmaceutical), Kalvista Pharmaceuticals Inc ($12.69 million of which 100% was Pharmaceuticals), and Pharmaxis Ltd ($8.41 million of which 56% was Mannitol).

Sales Analysis. During the year ended June of 2020, sales at Immutep Ltd were $9.34 million. This is an increase of 116.6% versus 2019, when the company's sales were $4.31 million. Sales of Cancer Immunotherapy saw an increase of 128.6% in 2020, from $4.03 million to $9.21 million.
  Stock Performance Chart for Immutep Ltd - ADR
  Stock Data: Recent Stock Performance:
  Current Price (10/16/2020): 1.69
(Figures in U.S. Dollars)
1 Week -1.2%   13 Weeks -10.6%  
4 Weeks 31.0%   52 Weeks -8.6%  
Immutep Ltd - ADR Key Data:
  Ticker: IMMP Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 9,342,776
(Year Ending Jan 2021).
Employees: 19
  Currency: U.S. Dollars Market Cap: 82,409,629
  Fiscal Yr Ends: June Shares Outstanding: 48,763,094
  Share Type: Common Closely Held Shares: 3,125,115
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.